Skip to content

high fat breakfast

OTHER9 trials

Sponsors

Maastricht University Medical Center, Boehringer Ingelheim, University of Alabama at Birmingham

Conditions

DiabetesHealthyHeart DiseasesPostprandial IHL and IMCL Dynamics

Phase 1

Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects
CompletedNCT02211157
Boehringer IngelheimHealthy
Start: 2000-03-31Updated: 2014-08-08
Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers
CompletedNCT02211937
Boehringer IngelheimHealthy
Start: 2007-01-31Updated: 2014-08-08
Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers
CompletedNCT02212938
Boehringer IngelheimHealthy
Start: 2006-09-30Updated: 2014-08-08
Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers
CompletedNCT02215746
Boehringer IngelheimHealthy
Start: 2008-01-31Updated: 2014-08-13
Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects
CompletedNCT02251158
Boehringer IngelheimHealthy
Start: 2003-10-31Updated: 2014-09-29
Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers
CompletedNCT02253927
Boehringer IngelheimHealthy
Start: 2006-05-31Updated: 2014-10-01
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects
CompletedNCT02259985
Boehringer IngelheimHealthy
Start: 1998-03-31Updated: 2014-10-09

Unknown Phase

Related Papers